Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 1.000 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.547 | |
4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.540 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.537 | |
3t8o | ATP | Rhodopsin kinase | / | 0.530 | |
3c4x | ATP | Rhodopsin kinase | / | 0.528 | |
4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.528 | |
4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.525 | |
4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.524 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.524 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.522 | |
3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.522 | |
3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.521 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.519 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.516 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.516 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.514 | |
4wbo | ANW | Rhodopsin kinase | / | 0.514 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.512 | |
3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.511 | |
4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.510 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.506 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.506 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.504 | |
4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.503 | |
1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.502 | |
1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.500 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.500 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.499 | |
4l9i | 8PR | Rhodopsin kinase | / | 0.499 | |
5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.499 | |
2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.498 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.498 | |
3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.498 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.497 | |
3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.497 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.496 | |
4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.496 | |
4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.496 | |
1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.495 | |
2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.495 | |
3c4w | ATP | Rhodopsin kinase | / | 0.495 | |
2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.493 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.492 | |
2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.492 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.492 | |
4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.492 | |
5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.492 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.491 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.491 | |
4b7t | CWT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.491 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.490 | |
4ct2 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.490 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.490 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.489 | |
3op5 | REB | Serine/threonine-protein kinase VRK1 | 2.7.11.1 | 0.489 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.489 | |
3beg | ANP | SRSF protein kinase 1 | 2.7.11.1 | 0.488 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.487 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.487 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.486 | |
3qc9 | ADP | Rhodopsin kinase | / | 0.486 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.486 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.486 | |
4jrn | ANP | Rhoptry kinase family protein | / | 0.486 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.486 | |
2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.485 | |
4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.485 | |
4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.485 | |
1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 0.484 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.484 | |
3c4z | ADP | Rhodopsin kinase | / | 0.484 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.484 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.484 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.484 | |
3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 0.483 | |
3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.483 | |
2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.482 | |
2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.482 | |
3pxk | PXK | Focal adhesion kinase 1 | 2.7.10.2 | 0.482 | |
4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.482 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.482 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.482 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.482 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.481 | |
1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.481 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.481 | |
2izt | 23D | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.481 | |
3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.481 | |
3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.481 | |
4aw1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.481 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.481 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.480 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.480 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.480 | |
4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.480 | |
4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.480 | |
4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.480 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.478 | |
4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.478 | |
2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.477 | |
2cjm | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.477 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
2yaa | ATP | Death-associated protein kinase 2 | / | 0.477 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.476 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.476 | |
4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.476 | |
2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.475 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.475 | |
2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.474 | |
2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.474 | |
3d7t | STU | Tyrosine-protein kinase CSK | / | 0.474 | |
3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.474 | |
3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.474 | |
1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.473 | |
2c4g | 514 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
2qhn | 582 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.473 | |
2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.473 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.472 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.472 | |
2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.471 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.471 | |
1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.470 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.470 | |
4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.470 | |
3iok | 1P6 | Tyrosine-protein kinase JAK2 | / | 0.469 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
4aw0 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.469 | |
1jqh | ANP | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.468 | |
2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.468 | |
2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.468 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.468 | |
4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.468 | |
4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.467 | |
5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.467 | |
1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.466 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.466 | |
3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.466 | |
4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.466 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.466 | |
4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.466 | |
1uu9 | BI3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.465 | |
2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
2wxv | WXV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
3a7j | ADP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.465 | |
3f7z | 34O | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.465 | |
3qcy | 3Q3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.465 | |
4fv3 | EK6 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.465 | |
2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.464 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.464 | |
4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.464 | |
4ekl | 0RF | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.464 | |
2csn | CKI | Casein kinase I homolog 1 | 2.7.11.1 | 0.463 | |
2ojj | 82A | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.463 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
4kio | G5K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.463 | |
1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
2ym5 | YM5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.462 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.462 | |
4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.462 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.461 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.461 | |
2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.461 | |
2wmv | ZYV | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.461 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.461 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.461 | |
1q3d | STU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.460 | |
4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.460 | |
4eny | J19 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.460 | |
1mp8 | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.459 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.459 | |
3blq | ATP | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.459 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.459 | |
4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.459 | |
4izy | 1J2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.459 | |
5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.458 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.458 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.458 | |
3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.458 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.458 | |
4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.458 | |
4i4e | 1BQ | Focal adhesion kinase 1 | 2.7.10.2 | 0.458 | |
3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
4qmy | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.457 | |
1gy3 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
2itx | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.456 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.456 | |
2wih | P48 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
2wpa | 889 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
2xrw | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.456 | |
4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.456 | |
4fl2 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.456 | |
4fyn | 0VE | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.456 | |
4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.456 | |
5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.456 | |
5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.456 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.455 | |
2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.455 | |
3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.455 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.454 | |
2chl | DKI | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.454 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.454 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.454 | |
4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
5ap7 | SVE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.454 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
2c5y | MTW | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.453 | |
3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.453 | |
4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.453 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.452 | |
2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.452 | |
2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
2buj | STU | Serine/threonine-protein kinase 16 | / | 0.452 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.452 | |
3qd0 | 3Q4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.452 | |
3vjn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
4b8l | A0P | Aurora kinase B-A | 2.7.11.1 | 0.452 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.452 | |
4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.452 | |
2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.451 | |
3lij | ANP | Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands | / | 0.451 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.451 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
4fl3 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.451 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.450 | |
2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.450 | |
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.450 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.450 | |
4gu9 | 4GU | Focal adhesion kinase 1 | 2.7.10.2 | 0.450 | |
4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.450 | |
4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.450 | |
5eg3 | ACP | Fibroblast growth factor receptor 2 | / | 0.450 | |
1pxo | CK7 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.449 | |
2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.449 | |
3otu | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.449 | |
4awi | AQ2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.449 | |
4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.449 | |
4f4p | 0SB | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.449 | |
4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.449 | |
4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.449 | |
4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.449 | |
4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.449 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.449 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.448 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.448 | |
2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
3hko | ANP | Calcium/calmodulin-dependent protein kinase with a kinase domain and 2 calmodulin-like EF hands | / | 0.448 | |
3llt | ANP | Protein serine/threonine kinase-1 | / | 0.448 | |
3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.448 | |
1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.447 | |
1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
2uzd | C85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.447 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
4fhk | 0U0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.446 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.446 | |
3gu6 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.446 | |
3nuu | JOZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
4bbf | O19 | Tyrosine-protein kinase JAK2 | / | 0.446 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.446 | |
4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.446 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.446 | |
4fg9 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.446 | |
4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.446 | |
4tv3 | ML9 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.446 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.445 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
3bhy | 7CP | Death-associated protein kinase 3 | / | 0.445 | |
3r73 | X87 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
4xhg | ADP | Uncharacterized protein | / | 0.445 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.445 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.444 | |
2w1f | L0F | Aurora kinase A | 2.7.11.1 | 0.444 | |
3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.444 | |
4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.444 | |
2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.443 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.443 | |
3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.443 | |
3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
3l1s | Z92 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.443 | |
3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.443 | |
3v5l | 0G1 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.443 | |
4eom | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.443 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.443 | |
2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.442 | |
2pe0 | 39Z | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
3kn5 | ANP | Ribosomal protein S6 kinase alpha-5 | 2.7.11.1 | 0.442 | |
3oro | AGS | Serine/threonine protein kinase | / | 0.442 | |
3r7y | Z04 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.442 | |
4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.442 | |
4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.442 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.442 | |
1ogu | ST8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
1vyw | 292 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.441 | |
2xru | 400 | Aurora kinase A | 2.7.11.1 | 0.441 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
3lfs | A07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
4acd | GR9 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.441 | |
4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.440 | |
2bmc | MPY | Aurora kinase A | 2.7.11.1 | 0.440 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.440 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.440 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.440 | |
3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.440 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
4ii5 | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.440 |